Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Oncotest

1993 FOUNDED
M&A STATUS
91-100 EMPLOYEES
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of cancer research services. The company is a contract research organization (CRO) providing discovery services for oncology. It specializes in in vivo pharmacology services and in vitro assays using commercially available and proprietary PDX-derived cell lines.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Primary Office
  • Am Flughafen 12-14
  • 79108 Freiburg
  • Germany

Oncotest Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Oncotest‘s full profile, request access.

Request full access to PitchBook

Oncotest Executive Team (3)

Name Title Board
Seat
Contact
Info
Sabine Gorynia Chief Executive Officer
Ingmar Peitz Chief Financial Officer
Heinz-Herbert Fiebig Geschäftsführer and Founder